Clinical TrialID 1426
Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
NCT01914627
Scalp Psoriasis
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 1426
- Evidence Id
- 1426
- Core Evidence Id
- 1426
- Source Clinical Trial Id
- 1406
- Herb2 Clinical Trial Id
- HBCT001406
- Nct Id
- NCT01914627
- Title
- Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Scalp Psoriasis
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Dimethicone|DRUG: Salicylic Acid
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 90
- Outcome Measure
- Change from Baseline in Scaling, To evaluate improvement of scaling of patients exposed to Loion or standard therapy for psoriasis capitis, at Day 7
- Sponsor Collaborator
- G. Pohl-Boskamp GmbH & Co. KG|Universitätsklinikum Hamburg-Eppendorf
- Funded By
- INDUSTRY
- Location
- University Medical Center Hamburg-Eppendorf (UKE), Hamburg, 20246, Germany
- Other Id
- 0741/179
- Start Date
- 2013-08
- Primary Completion Date
- 2014-01
- Completion Date
- 2014-01
- First Posted
- 2013-08-02
- Results First Posted
- Last Update Posted
- 2014-11-05
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01914627
- Title Cn
- Title En
- Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
- Bilingual Status
- semi_complete